000			02099 a2200589 4500
005			20250516144352.0
264		0	_c20140206
008			201402s 0 0 eng d
022			_a1179-1926
024	7		_a10.1007/s40262-013-0064-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aPoi, Ming J
245	0	0	_aStandard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease. _h[electronic resource]
260			_bClinical pharmacokinetics _cAug 2013
300			_a705-12 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article
650	0	4	_aAdenosine Deaminase Inhibitors _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aArea Under Curve
650	0	4	_aBlood Transfusion, Autologous
650	0	4	_aCreatinine _xblood
650	0	4	_aCyclosporine _xadministration & dosage
650	0	4	_aDrug Resistance
650	0	4	_aFemale
650	0	4	_aGraft vs Host Disease _xblood
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aInfliximab
650	0	4	_aLymphocyte Transfusion
650	0	4	_aMale
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMethylprednisolone _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aPentostatin _xadministration & dosage
650	0	4	_aRenal Insufficiency _xblood
650	0	4	_aStem Cell Transplantation
650	0	4	_aTacrolimus _xadministration & dosage
650	0	4	_aYoung Adult
700	1		_aHofmeister, Craig C
700	1		_aJohnston, Jeffrey S
700	1		_aEdwards, Ryan B
700	1		_aJansak, Buffy S
700	1		_aLucas, David M
700	1		_aFarag, Sherif S
700	1		_aDalton, James T
700	1		_aDevine, Steven M
700	1		_aGrever, Michael R
700	1		_aPhelps, Mitch A
773	0		_tClinical pharmacokinetics _gvol. 52 _gno. 8 _gp. 705-12
856	4	0	_uhttps://doi.org/10.1007/s40262-013-0064-7 _zAvailable from publisher's website
999			_c22671726 _d22671726